Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ozette Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ozette Technologies

Ozette Technologies

Ozette: An AI-enabled life sciences startup specializing in immune monitoring.

HQ
Seattle, WA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Ozette Technologies was founded with the core mission to revolutionize life sciences through advanced data analytics. The company specializes in developing an AI-enabled immune monitoring platform that aims to unlock the secrets of the immune system. By leveraging artificial intelligence, Ozette provides detailed mapping and analysis of the immune system, facilitating accelerated research and personalized healthcare solutions. Their market focus includes pharmaceutical companies, research institutions, and healthcare providers seeking to deepen their understanding of immune responses.

Notable affiliated individuals include experts in immunology and data science, although specific names are not provided. The company has attracted significant interest from investors in the biotech and AI sectors. Key achievements include the development of a robust platform capable of detailed immune system analysis, which has already shown promise in accelerating research outcomes. Overall, Ozette Technologies is making a substantial impact by providing tools that enhance the precision and efficiency of immune system research.

Ozette Technologies - Similar Companies

Omix.ai logo

Omix.ai

Immunai logo

Immunai

Destined AI logo

Destined AI

destined.ai

CellChorus logo

CellChorus

cellchorus.com

l'école AI logo

l'école AI

lecole.ai

Stateoftheart AI logo

Stateoftheart AI

ImmuneID logo

ImmuneID

Zeteo Tech logo

Zeteo Tech

zeteotech.com

Zephyr AI logo

Zephyr AI

zephyrai.bio

Limmi logo

Limmi

limmi.io

Ambit.AI logo

Ambit.AI

ambit.ai

ImmunoMind logo

ImmunoMind

Zone7 logo

Zone7

zone7.ai

Owkin logo

Owkin

owkin.com

Noetik logo

Noetik

noetik.ai

Ozette Technologies - Quick Facts

Who are Ozette Technologies' competitors?

Companies similar to Ozette Technologies include Omix.ai, Immunai, Destined AI and CellChorus.

When was Ozette Technologies founded?

Ozette Technologies was founded in 2021.

Where is Ozette Technologies' headquarters located?

Ozette Technologies' headquarters is located in Seattle, WA, US.

When was Ozette Technologies' last funding round?

Ozette Technologies' most recent funding round was for $26M (USD) in July 2022.

How much has Ozette Technologies raised to-date?

As of Jul 28, 2022, Ozette Technologies has raised a total of $32M (USD).

How many employees does Ozette Technologies have?

Ozette Technologies has 48 employees as of Feb 5, 2024.

Ozette Technologies - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immune Monitoring
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software